Lineage Cell Therapeutics
Price & Volume
Stats
See more52W Range | $0.64-$2.09 |
Market Cap | $324M |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $14.7M |
Revenue Growth (YoY) | 14.8% |
Gross Profit (12 Mos) | -$3M |
Diluted EPS | -$0.29 |
News
See moreYahoo Finance • 13 days ago
Lineage targets operations into Q2 2028 as it launches COR1 and scales ILT1 manufacturing
Yahoo Finance • 3 months ago
Lineage extends cash runway into Q2 2028 while advancing OpRegen and new pipeline programs
Yahoo Finance • 4 months ago
trivago Leads The Pack Of 3 Promising Penny Stocks
Yahoo Finance • 6 months ago
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care
About
CEO | Mr. Brian M. Culley M.A., M.B.A. |
Address | 2173 Salk Avenue, Carlsbad, CA, United States, 92008 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 72 |